Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients.

International journal of hematology - 1 Jun 2020

Zhou Xuan, Zheng Meihong, Wang Qien, Aa Jiye, Cao Bei, Li Juan

Abstract excerpt

There is an ongoing search for potential biomarkers for acute myeloid leukemia (AML) patients using metabolic analysis. However, only few studies to date have focused on bone marrow samples or a specific subtype of AML. In the present study, we used gas chromatography time-of-flight mass spectrometry of plasma and bone marrow supernatants to compare the metabolic characteristics of patients with AML with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Biomarkers, Tumor
Share to Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lysine

Share to Metabolomics

Share to Prognosis

Share to Taurine

Source

Identifiers

PMID: 32056080
DOI: 10.1007/s12185-020-02836-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients.PMID 32056080Read ↗

Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemiaSemantic proximity Read ↗

Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy.Semantic proximity Read ↗

In vivo metabolomic study uncovers distinct metabolic phenotypes of host tissues and predicts oxidative state of acute myeloid leukemiaSemantic proximity Read ↗

The metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker.Semantic proximity Read ↗

Identification of glucuronic acid as a biomarker of poor prognosis in acute myeloid leukemia based on plasma metabolomicsSemantic proximity Read ↗

Metabolism in acute myeloid leukemia: mechanistic insights and therapeutic targetsSemantic proximity Read ↗

Mechanisms of T‑cell metabolic reprogramming in the microenvironment of acute myeloid leukemia and its therapeutic potential (Review)Semantic proximity Read ↗

Distinct Metabolic features differentiating FLT3-ITD AML from FLT3-WT childhood Acute Myeloid Leukemia.Semantic proximity Read ↗

Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations.Semantic proximity Read ↗

Acute Myeloid Leukaemia Drives Metabolic Changes in the Bone Marrow NicheSemantic proximity Read ↗

Targeting Amino Acid Metabolic Vulnerabilities in Myeloid MalignanciesSemantic proximity Read ↗

NMR-Based Metabolomic Analysis of the Molecular Pathogenesis of Therapy-Related Myelodysplasia/Acute Myeloid LeukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.